IMS MAXIMS Forms e-Prescribing Partnership with Better by Marand

IMS MAXIMSIMS MAXIMS has formed a partnership with Better by Marand to become a reseller for its e-prescribing system, OPENeP. The move gives NHS trusts that want to progress their digital maturity the option to buy an e-prescribing system that integrates seamlessly with the MAXIMS software suite.

The model has already been successfully adopted by Taunton and Somerset NHS Foundation Trust, a global digital exemplar, which uses MAXIMS and is due to go live with OPENeP this summer.

Leesa Ewing, the commercial director at IMS MAXIMS, said: “E-prescribing is recognised as one of the key components of an electronic patient record. In the past, we have been happy to work with any system that our customers have wanted to use to achieve this; and we will maintain the valued relationships that we have with suppliers so we can continue to do this in the future.

"However, the partnership with Better by Marand will enable us to integrate our EPR with OPENeP, and to create a seamless experience for clinicians. That should give trusts additional confidence that they will achieve the well-documented benefits of e-prescribing, which include fewer medication errors and, critically, improved patient safety."

Both IMS MAXIMS and Better by Marand are committed to using open architecture and open standards so their systems can interoperate with others.

This is in line with the refresh of NHS digital policy instituted with health and social care secretary Matt Hancock, who has repeatedly emphasised the need for systems that can “talk to each other.”

The NHS is also being encouraged to accelerate the roll-out of e-prescribing, for which the government set-aside a pot of £75 million in 2018. Thirteen trusts have received funding to date, and 48 bids are being considered for a second wave of funding, according to a recent Parliamentary answer.

OPENeP by Better by Marand product manager Roko Malkoč said: "It is our common goal with IMS MAXIMS to improve outcomes for patients. We both work closely with the medical staff to make sure that we have identified the problems to be solved and prevent unnecessary errors.

"It is our belief that this synergy will help us build the best possible products to improve patient safety and start a new collaboration engine among the medical staff."

IMS MAXIMS already has a partnership in place with JAC so they can continue to use its specialist pharmacy stock-control capabilities. Taunton and Somerset NHS Foundation Trust will use JAC software to run its pharmacy when it goes live with its new e-prescribing system.

About IMS MAXIMS

IMS MAXIMS is an award-winning clinical technology specialist, committed to improving the coordination of patient care in healthcare environments. Its expert team works in partnership with healthcare organisations to identify and deliver tailored, sustainable information sharing technology solutions supporting the provision of safer and more efficient care for current and future generations.

The organisation's 32-year history of collaborating with healthcare professionals has resulted in the development of proven, flexible, user-friendly, safe and interoperable electronic patient record software. The company’s approach to digital transformation also delivers better clinical engagement and empowerment across hospital wards and departments. Deployment times are fast, meaning clinicians and patients can benefit from efficiency and safety improvements in rapid time. And with an ambition to meet today’s healthcare challenges, IMS MAXIMS offers flexible options to support healthcare providers with on-going implementation and maintenance.

About Better by Marand

Better by Marand is one of Europe's leading healthcare IT solution and professional service providers. They collaborate with a variety of clients on the same goal - to set them up for the future. The future that moves towards open platforms and away from siloed solutions. The future where clinical teams can work with any digital solution provider without being tied to a particular vendor. In turn, storing data in an open, vendor-neutral format will incite vendors to innovate and create better solutions.

Their core technology solution, the Better Platform, is well-aligned with this vision and is based on openEHR specifications. Their OPENeP by Better product (a closed-loop medication management system) is built on top of the Better Platform and follows the same vision. Their innovations have so far taken them to 3 continents and 15 markets, including the UK, the Netherlands, Germany, Malta, Russia, Norway, Finland, Italy and Slovenia.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...